| Medgenics Provides Clinical and Regulatory Update - MarketWatch (press release) |
|
|
MarketWatch (press release) "We look forward to the presentation of the updated results of our Phase I/II dose-ranging trial of EPODURE to treat anemia in pre-dialysis, chronic kidney disease patients in a poster presentation on November 11th at the American Society of |